Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9044468 | 0.85 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL12261633 | 0.85 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL1872205 | 0.84 | PDE5A (0.49) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL28998748 | 0.84 | ALDH1A1 (0.40) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL3141663 | 0.84 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL16712808 | 0.84 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL9046753 | 0.80 | PGK1 (0.41) | ALDH1A1LMNASMN1; SMN2AURKAPDE5A | |
| SCHEMBL13019497 | 0.80 | ALDH1A1 (0.36) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL7199405 | 0.79 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA | |
| SCHEMBL8419304 | 0.79 | ENPP1 (0.45) | ALDH1A1LMNASMN1; SMN2ENPP1AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591549-A | Rapid synthesis method of polysubstituted pyrimidine carboxylic acid compound | 南通益昊药业有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119500263-A | Catalyst and method for preparing 5-methoxy-4, 6-dichloropyrimidine through Kjeldahl reaction | 江苏金申医药科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-118812441-A | Industrial sulfanilamide production and preparation process | 安达裕顺化工有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-116693461-A | Novel synthetic method of 4, 6-dichloro-5-methoxypyrimidine | 江苏中渊化学品有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-217423842-U | High-efficient drying device is used in production of 4, 6-dichloro-5-methoxy pyrimidine | 江苏金申医药科技有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-217221487-U | Multifunctional reaction kettle for producing 4, 6-dichloro-5-methoxypyrimidine | 江苏金申医药科技有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-217092129-U | Energy-saving distillation device for preparing 4, 6-dichloro-5-methoxypyrimidine | 江苏金申医药科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-217092105-U | Cooling device is used in production of 4, 6-dichloro-5-methoxy pyrimidine | 江苏金申医药科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-212441190-U | Environment-friendly preparation equipment of 5-methoxy-4, 6-dichloropyrimidine | 常熟市金申医化制品有限责任公司 | 2021-02-02 | — | — | CN | claimed |
| CN-108658871-B | Preparation method of sulfadoxine intermediate 4, 6-dichloro-5-methoxypyrimidine | 舞阳威森生物医药有限公司 | 2020-10-30 | — | — | CN | claimed |
| CN-111484456-A | Refining process of 5-methoxy-4, 6-dichloropyrimidine | 常熟市金申医化制品有限责任公司 | 2020-08-04 | — | — | CN | claimed |
| CN-110256461-A | Thick miscellaneous pyrimidine derivatives and its preparation method and application | 江西中医药大学 | 2019-09-20 | — | — | CN | claimed |
| CN-110003120-A | A kind of sulfadoxine and its synthetic method of stable isotope labeling | 上海安谱实验科技股份有限公司 | 2019-07-12 | — | — | CN | claimed |
| CN-108658871-A | The preparation method of sulfamethoxine intermediate 4,6- dichloro-5-methoxy pyrimidines | 张家港威胜生物医药有限公司 | 2018-10-16 | — | — | CN | claimed |
| CN-105153044-A | Method for one-pot synthesis of sulfadoxine by monitoring reaction progress through HPLC | GUILIN PHARMACEUTICAL CO LTD | 2015-12-16 | — | — | CN | claimed |
| CN-104370831-A | Sulfadoxine production process | CHANGSHU JINSHEN MEDICAL AND CHEMICAL PRODUCT CO LTD | 2015-02-25 | — | — | CN | claimed |
| CN-102304094-B | Preparation method of sulfadoxine and intermediate thereof | CHANGSHU NANHU IND CHEMICAL CO LTD | 2014-03-26 | — | — | CN | claimed |
| CN-102304095-B | Preparation method of sulfadoxine | CHANGSHU NANHU IND CHEMICAL CO LTD | 2013-10-16 | — | — | CN | claimed |
| US-20260146124-A1 | RESIN COMPOSITION AND USES OF THE SAME | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2026-05-28 | — | — | US | disclosed |
| US-5077293-A | Antidepressants | BRISTOL-MYERS SQUIBB CO. (US) | 1991-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146124-A1 | RESIN COMPOSITION AND USES OF THE SAME | ARCN1, ASH2L, ITGA1 | ALDH1A1 868/4885LMNA 1292/4885SMN1; SMN2 894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.